ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

122
Analysis
Health CareJapan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
Refresh
05 Sep 2016 13:45

Short Sell Research Vs The Japan Stock Market Blob

Two recent press articles "Muddy Waters and Andrew Left: the short sellers having a ball" (...

29 Aug 2016 22:03

Japan Pharma Hits 52 Week Low

The Topix pharmaceutical index (TPPHRM) fell to 2,355 just after the lunch break in Tokyo on Friday 19th August, before recovering to 2,377, with...

bullishAstellas Pharma
24 Aug 2016 06:24

Astellas: Pfizer Buying Medivation Is the Best Possible Outcome for the Japan Pharma Firm

Pfizer is to pay US$81.50/shr for Medivation, considerably above Sanofi’s original offer of US$52.5bil. This values the Xtandi-originator at...

20 Aug 2016 01:02

JAPAN FLOW III:  The Mechanics of BOJ Buying

This is the latest in a series of JAPAN FLOW regarding recent and forward flow dynamics of Japan equities.The first two are:    JAPAN FLOW I:  The...

Logo
330 Views
Share
09 Aug 2016 18:52

A 'heads Up' on Changing World Heights

A comprehensive world survey of population heights over the last century has thrown up some surprising results. Americans have had the smallest...

Logo
Bixmoor
165 Views
Share
x